ANANDA PHARMA LTD ("Ananda" or the "Company") : MHRA and NHS Ethics Approval Received for ENDOCAN Phase 2 Clinical Trial for Endometriosis

Ananda's CEO, Melissa Sturgess commented: "The personal and societal burden of endometriosis is staggering and it is appalling that more is not being done to find useful treatments for this ...
Pharmabiz

Ananda Pharma gets UK MHRA and NHS Ethics approvals for ENDOCAN phase 2 trial for management of endometriosis associated pain

Ananda Pharma gets UK MHRA and NHS Ethics approvals for ENDOCAN phase 2 trial for management of endometriosis associated pain: United Kingdom Thursday, March 5, 2026, 18:00 Hrs [I ...
Odessa American

ANANDA Scientific and NYU Grossman School of Medicine Announce Second Clinical Trial Utilizing Liquid StructureTM Cannabidiol (CBD) for Evaluating Its Effect on Opioid Sparing ...

ANANDA Scientific Inc., a biotech pharma company, and NYU Grossman School of Medicine today announced a second clinical trial to evaluate the effect of cannabidiol in ANANDA’s proprietary delivery ...
Investing

Ananda's MRX1 CBD drug candidate clears stability tests

LONDON - Ananda Developments PLC (AQSE: ANA), a life sciences company engaged in developing cannabidiol (CBD) therapies, has announced the successful completion of significant drug stability ...
Business Wire

ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of ...

GREENWOOD VILLAGE, Colo. & NEW YORK--(BUSINESS WIRE)--ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been ...
Business Insider

ECOFIBRE'S ANANDA HEALTH DIVISION and MEDISCA Announce Exclusive Partnership for Global Distribution of Full Spectrum CBD

Georgetown, KY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Ecofibre's Ananda Health Division, the leading provider of CBD to US independent pharmacies is pleased to announce that it has partnered with MEDISCA ...
Business Insider

Ecofibre, Ananda Health Division - New Study Suggests CBD May Reduce or Eliminate Opioid Usage & Improve Quality of Life Measures

CYNTHIANA, Ky., Nov. 14, 2019 /PRNewswire/ -- Ecofibre Limited (Ecofibre, Company) (ASX: EOF, OTC – Nasdaq Intl Designation: EOFBF) today announced publication of the results of an 8-week study on ...
Investing

Ananda Pharma advances CBD drug with Phase 1 study listing

The study focuses on MRX1, Ananda’s lead investigational cannabidiol (CBD) drug, which is being developed to treat chronic inflammatory pain conditions. The company, which specializes in creating ...